Vascular endothelial growth factor reduces Fas-mediated acute liver injury in mice

Journal of Gastroenterology and Hepatology (Australia)

Volumn 23, Issue 7 PT2, 2008, Pages

  Tanaka, Yoichi ^a   Sohda, Tetsuro ^b   Matsuo, Katsuhiko ^a   Anan, Akira ^b   Irie, Makoto ^b   Takeyama, Yasuaki ^b   Iwata, Kaoru ^b   Shakado, Satoshi ^b   Sakisaka, Shotaro ^b  

^a Base Technology Center   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

Author keywords

Apoptosis; Endothelial cells; Fulminant liver failure; Vascular endothelial growth factor

Indexed keywords

ALANINE AMINOTRANSFERASE; FAS ANTIBODY; FAS ANTIGEN; PROTEIN BCL X; RECOMBINANT VASCULOTROPIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BAGG ALBINO MOUSE; CONTROLLED STUDY; ENZYME REPRESSION; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER FAILURE; LIVER HISTOLOGY; LIVER INJURY; MALE; MOUSE; NONHUMAN; PREMEDICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 47649100199     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2007.05135.x     Document Type: Article

References (20)

1. Hoofnagle JH, Carithers RL Jr, Shapiro C, Ascher N. Fulminant hepatic failure: summary of a workshop. Hepatology 1995 21 : 240 52.
2. Lee WM. Acute liver failure. N. Engl. J. Med. 1993 329 : 1862 72.
3. Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis. Annu. Rev. Immunol. 1995 13 : 29 60.
4. Galle PR, Hofmann WJ, Walczak H et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J. Exp. Med. 1995 182 : 1223 30.
5. Rodriguez I, Matsuura K, Khatib K, Reed JC, Nagata S, Vassalli P. A bcl-2 transgene expressed in hepatocytes protects mice from fulminant liver destruction but not from rapid death induced by anti-Fas antibody injection. J. Exp. Med. 1996 183 : 1031 6.
6. Lacronique V, Mignon A, Fabre M et al. Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice. Nat. Med. 1996 2 : 80 6.
7. Kondo T, Suda T, Fukuyama H, Adachi M, Nagata S. Essential roles of the Fas ligand in the development of hepatitis. Nat. Med. 1997 3 : 409 13.
8. Ryo K, Kamogawa Y, Ikeda I et al. Significance of Fas antigen-mediated apoptosis in human fulminant hepatic failure. Am. J. Gastroenterol. 2000 95 : 2047 55.
9. Pan HN, Hong F, Radaeva S, Gao B. Hydrodynamic gene delivery of interleukin-22 protects the mouse liver from concanavalin A-, carbon tetrachloride-, and Fas ligand-induced injury via activation of STAT. Cell. Mol. Immunol. 2004 1 : 43 9.
10. Zucchini N, de Sousa G, Bailly-Maitre B et al. Regulation of Bcl-2 and Bcl-xL anti-apoptotic protein expression by nuclear receptor PXR in primary cultures of human and rat hepatocytes. Biochim. Biophys. Acta 2005 1745 : 48 58.
11. Kosai K, Matsumoto K, Nagata S, Tsujimoto Y, Nakamura T. Abrogation of Fas-induced fulminant hepatic failure in mice by hepatocyte growth factor. Biochem. Biophys. Res. Commun. 1998 244 : 683 90.
12. Asano M, Yukita A, Matsumoto T, Matsuo K, Kondo S, Suzuki H. Isolation and characterization of neutralizing monoclonal antibodies to human vascular endothelial growth factor/vascular permeability factor121 (VEGF/VPF121). Hybridoma 1995 14 : 475 80.
13. Kondo S, Matsumoto T, Yokoyama Y, Ohmori I, Suzuki H. The shortest isoform of human vascular endothelial growth factor/vascular permeability factor (VEGF/VPF121) produced by Saccharomyces cerevisiae promotes both angiogenesis and vascular permeability. Biochim. Biophys. Acta 1995 1243 : 195 202.
14. Labat-Moleur F, Guillermet C, Lorimier P et al. TUNEL apoptotic cell detection in tissue sections; critical evaluation and improvement. J. Histochem. Cytochem. 1998 46 : 327 34.
15. Koga H, Sakisaka S, Ohishi M, Sata M, Tanikawa K. Nuclear DNA fragmentation and expression of Bcl-2 in primary biliary cirrhosis. Hepatology 1997 25 : 1077 84.
16. LeCouter J, Moritz DR, Li B et al. Angiogenesis-independent endothelial protection of liver: role of VEGF-1. Science 2003 299 : 890 3.
17. Kaya M, Wada T, Akatsuka T et al. Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis. Clin. Cancer Res. 2000 6 : 572 7.
18. Saito H, Tujitani S, Ikeguchi M, Maeta M, Kaibara N. Neoangiogenesis and relationship to nuclear p53 accumulation and vascular endothelial growth factor expression in advanced gastric carcinoma. Oncology 1999 57 : 164 72.
19. Mori A, Arii S, Furutani M et al. Vascular endothelial growth factor-induced tumor angiogenesis and tumorigenicity in relation to metastasis in a HT1080 human fibrosarcoma cell model. Int. J. Cancer 1999 80 : 738 43.
20. Taniguchi E, Sakisaka S, Matsuo K, Tanikawa K, Sata M. Expression and role of vascular endothelial growth factor in liver regeneration after partial hepatectomy in rats. J. Histochem. Cytochem. 2001 49 : 121 9.